These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 14662904)

  • 1. Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.
    Sun P; Schwenk R; White K; Stoute JA; Cohen J; Ballou WR; Voss G; Kester KE; Heppner DG; Krzych U
    J Immunol; 2003 Dec; 171(12):6961-7. PubMed ID: 14662904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.
    Wang R; Epstein J; Charoenvit Y; Baraceros FM; Rahardjo N; Gay T; Banania JG; Chattopadhyay R; de la Vega P; Richie TL; Tornieporth N; Doolan DL; Kester KE; Heppner DG; Norman J; Carucci DJ; Cohen JD; Hoffman SL
    J Immunol; 2004 May; 172(9):5561-9. PubMed ID: 15100299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
    Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J
    J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with the RTS,S/AS malaria vaccine induces IFN-γ(+)CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge.
    Schwenk R; Lumsden JM; Rein LE; Juompan L; Kester KE; Heppner DG; Krzych U
    Vaccine; 2011 Nov; 29(48):8847-54. PubMed ID: 21983360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique.
    Barbosa A; Naniche D; Aponte JJ; Manaca MN; Mandomando I; Aide P; Sacarlal J; Renom M; Lafuente S; Ballou WR; Alonso PL
    Infect Immun; 2009 Oct; 77(10):4502-9. PubMed ID: 19651872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.
    Stewart VA; McGrath SM; Dubois PM; Pau MG; Mettens P; Shott J; Cobb M; Burge JR; Larson D; Ware LA; Demoitie MA; Weverling GJ; Bayat B; Custers JH; Dubois MC; Cohen J; Goudsmit J; Heppner DG
    Infect Immun; 2007 May; 75(5):2283-90. PubMed ID: 17307942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population.
    Kusi KA; Aggor FE; Amoah LE; Anum D; Nartey Y; Amoako-Sakyi D; Obiri-Yeboah D; Hollingdale M; Ganeshan H; Belmonte M; Peters B; Kim Y; Tetteh J; Kyei-Baafour E; Dodoo D; Villasante E; Sedegah M
    PLoS One; 2020; 15(2):e0228177. PubMed ID: 32040522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.
    Radosevic K; Rodriguez A; Lemckert AA; van der Meer M; Gillissen G; Warnar C; von Eyben R; Pau MG; Goudsmit J
    Clin Vaccine Immunol; 2010 Nov; 17(11):1687-94. PubMed ID: 20826614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.
    Chawla B; Mahajan B; Oakley M; Majam VF; Belmonte A; Sedegah M; Shimp RL; Kaslow DC; Kumar S
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
    Olotu A; Moris P; Mwacharo J; Vekemans J; Kimani D; Janssens M; Kai O; Jongert E; Lievens M; Leach A; Villafana T; Savarese B; Marsh K; Cohen J; Bejon P
    PLoS One; 2011; 6(10):e25786. PubMed ID: 21998698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D).
    Agnandji ST; Fendel R; Mestré M; Janssens M; Vekemans J; Held J; Gnansounou F; Haertle S; von Glasenapp I; Oyakhirome S; Mewono L; Moris P; Lievens M; Demoitie MA; Dubois PM; Villafana T; Jongert E; Olivier A; Cohen J; Esen M; Kremsner PG; Lell B; Mordmüller B
    PLoS One; 2011 Apr; 6(4):e18559. PubMed ID: 21494604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.
    Kazmin D; Nakaya HI; Lee EK; Johnson MJ; van der Most R; van den Berg RA; Ballou WR; Jongert E; Wille-Reece U; Ockenhouse C; Aderem A; Zak DE; Sadoff J; Hendriks J; Wrammert J; Ahmed R; Pulendran B
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2425-2430. PubMed ID: 28193898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.
    Sedegah M; Hollingdale MR; Farooq F; Ganeshan H; Belmonte M; Kim Y; Peters B; Sette A; Huang J; McGrath S; Abot E; Limbach K; Shi M; Soisson L; Diggs C; Chuang I; Tamminga C; Epstein JE; Villasante E; Richie TL
    PLoS One; 2014; 9(9):e106241. PubMed ID: 25211344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-Directed AAV8 Booster Vaccine Expressing
    Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
    Front Immunol; 2021; 12():612910. PubMed ID: 34248928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.
    Mettens P; Dubois PM; Demoitié MA; Bayat B; Donner MN; Bourguignon P; Stewart VA; Heppner DG; Garçon N; Cohen J
    Vaccine; 2008 Feb; 26(8):1072-82. PubMed ID: 18258343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies.
    López JA; Weilenman C; Audran R; Roggero MA; Bonelo A; Tiercy JM; Spertini F; Corradin G
    Eur J Immunol; 2001 Jul; 31(7):1989-98. PubMed ID: 11449351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.